Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Open in API
Filings indexed 746 across all filing types
Latest filing 2014-09-25 Regulatory Filings
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a letter from Xenon Pharmaceuticals Inc. to the SEC staff regarding the review of the company's Registration Statement on Form S-1 filed on September 10, 2014. It discusses option pricing, fair value determinations, and provides updates related to the company's initial public offering (IPO) price range and related valuation factors. The letter references the Registration Statement and Management's Discussion and Analysis (MD&A) section but does not itself contain financial statements or substantive financial data. It is a correspondence related to regulatory review and compliance, not a financial report or earnings release. The document is a regulatory correspondence or filing related to the registration process and SEC review, fitting best under Regulatory Filings (RNS).
2014-09-25 English
Regulatory Filings 2014
Regulatory Filings
2014-09-22 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for initial public offerings (IPOs) to register securities under the Securities Act of 1933. It includes detailed information about the company, its business, financials, risk factors, management, and the offering itself. This type of filing is distinct from annual reports, earnings releases, or other financial reports. It is a capital markets filing related to the registration of securities for public sale, not a report on financial performance or governance. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities, including IPO registration statements.
2014-09-10 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a letter from a company (Xenon Pharmaceuticals Inc.) responding to comments from the SEC staff regarding an Amendment #2 to a Draft Registration Statement on Form S-1. It discusses revisions to the Registration Statement and submission of Amendment No. 3. The content is focused on regulatory correspondence related to a registration statement filing, not the filing itself. The document is relatively short (4573 characters) and is a letter of response rather than a full report or prospectus. This fits the profile of a Regulatory Filing (RNS), which includes correspondence and compliance documents that do not fit other categories. It is not an Annual Report, Prospectus, or other financial report, nor is it a report publication announcement since it contains substantive responses to SEC comments rather than just announcing a report's availability.
2014-08-20 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 100% confidence The document is a confidential draft registration statement on Form S-1 submitted to the SEC for Xenon Pharmaceuticals Inc. It includes a preliminary prospectus for an initial public offering (IPO) of common shares. The text contains detailed information about the company, its business, management, financial condition, risk factors, and the offering terms. Form S-1 is a registration statement used for securities offerings, specifically IPOs, and is not a financial report like an annual or quarterly report. It is a capital markets filing related to fundraising and securities issuance. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2014-08-20 English
Regulatory Filings 2014
Regulatory Filings
2014-04-09 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.